Showing 1501-1510 of 4166 results for "".
Delegate Efficiently
https://modernod.com/mod-issues/2026-mar-apr/delegate-efficiently/56847/Consider these tips on doing more by doing less.93. Thriving, Not Just Surviving: A Mental Health Check-In for New Grads ft. Dr. Meenal Agarwal
https://modernod.com/podcasts/four-eyes/93-thriving-not-just-surviving-a-mental-health-check-in-for-new-grads-ft-dr-meenal-agarwal/37043/In this refreshingly honest episode, we chat with Dr. Meenal Agarwal, an Optometrist and private practice owner, about the mental health challenges that often come with life after optometry school.Geared toward students and new grads, this conversation covers:•What burnout really feels like and whenTryptyr Now Available in US
https://modernod.com/podcasts/eyewire-news-the-podcast/tryptyr-now-available-in-us/37095/Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoicesWhat's the Big Deal With Dry Eye and OSD?
https://modernod.com/videos/eye-care-insiders/whats-the-big-deal-with-dry-eye-and-osd/37358/With this year's American Optometric Association meeting fresh in his mind, Joseph J. Allen, OD, FAAO, Dipl ABO, has some highlights to share. Hear his thoughts on why there was so much talk about dry eye and the ocular surface, his observation on how the meeting's continuing education has changed oFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesAlcon Gains FDA Approval for Novel DED Drug
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-gains-fda-approval-for-novel-ded-drug/37087/Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials. Learn more abIs it Dry Eye or Corneal Pathology?
https://modernod.com/podcasts/to-the-point/is-it-dry-eye-or-corneal-pathology/36946/Bita Asghari, OD, FAAO, FSLS, joins co-hosts Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, on this episode of the To the Point podcast to share her insights on managing corneal pathology in the setting of dry eye symptoms. They discuss signs to look for in cases of limbal stem celOculomics • IPL & Ocular Rosacea
https://modernod.com/podcasts/the-mod-pod/oculomics-ipl-ocular-rosacea/36881/Join Cecelia Koetting, OD, FAAO, Dipl ABO, on this month's episode of The MOD Pod as she learns about how imaging and biomarkers can be used to diagnose, manage, and treat ocular and systemic conditions (aka oculomics) from Modern Optometry contributor Shane Kannarr, OD. Dr. Koetting's second guestDetecting, Quantifying, and Managing HOAs
https://modernod.com/podcasts/the-mod-pod/detecting-quantifying-and-managing-hoas/36868/Cecelia Koetting, OD, FAAO, Dipl ABO, closes out The MOD Pod's last episode of 2025 with a discussion on aberrations in refractive cataract surgery with Nick Bruns, OD, FAAO. With modern technology, Dr. Bruns emphasizes that understanding the effect of higher-order aberrations helps optometrists betNutrition in Medicine • Inflammatory Dry Eye
https://modernod.com/podcasts/the-mod-pod/nutrition-in-medicine-inflammatory-dry-eye/36864/Cecelia Koetting, OD, FAAO, Dipl ABO, invites guest Julie Poteet, OD, MS, CNS, FOWNS, to the episode to talk about nutrition's role in the medical field and how it affects patients' ocular and systemic health. Dr. Koetting also speaks with Thomas Kislan, OD, on the topic of inflammatory dry eye. The